Skip to main content



Eckert & Ziegler with Unchanged Dividend Proposal

24.03.2023 /

Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) closed FY 2022 with sales of 222.3 million EUR. Net income for the year rose by around 20% compared to the previous year's figure adjusted for special effects and reached 29.3 million EUR, which corresponds to earnings per share of 1.41 EUR. Based on these figures, Executive Board and Supervisory Board decided today to propose to the Annual General Meeting the payment of a dividend of EUR 0.50 per dividend-bearing share, as in the previous year.

The detailed annual financial statements for 2022 and the forecast for FY 2023 will be published on 30 March 2023. Eckert & Ziegler is again listed in the TecDAX since 20 March 2023.

About Eckert & Ziegler.
Eckert & Ziegler Strahlen- und Medizintechnik AG with nearly 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.

Source: Press Release EZAG
Eckert & Ziegler with Unchanged Dividend Proposal

Overview News